177 related articles for article (PubMed ID: 2008803)
1. Construction of aromatic dependent Shigella flexneri 2a live vaccine candidate strains: deletion mutations in the aroA and the aroD genes.
Verma NK; Lindberg AA
Vaccine; 1991 Jan; 9(1):6-9. PubMed ID: 2008803
[TBL] [Abstract][Full Text] [Related]
2. Live oral auxotrophic Shigella flexneri SFL124 vaccine with a deleted aroD gene: characterization and monkey protection studies.
Kärnell A; Stocker BA; Katakura S; Reinholt FP; Lindberg AA
Vaccine; 1992; 10(6):389-94. PubMed ID: 1598787
[TBL] [Abstract][Full Text] [Related]
3. Construction of an auxotrophic Shigella flexneri strain for use as a live vaccine.
Lindberg AA; Karnell A; Pál T; Sweiha H; Hultenby K; Stocker BA
Microb Pathog; 1990 Jun; 8(6):433-40. PubMed ID: 2266855
[TBL] [Abstract][Full Text] [Related]
4. Development of an auxotrophic oral live Shigella flexneri vaccine.
Lindberg AA; Kärnell A; Stocker BA; Katakura S; Sweiha H; Reinholt FP
Vaccine; 1988 Apr; 6(2):146-50. PubMed ID: 2838986
[TBL] [Abstract][Full Text] [Related]
5. Attenuated Shigella flexneri 2a Delta guaBA strain CVD 1204 expressing enterotoxigenic Escherichia coli (ETEC) CS2 and CS3 fimbriae as a live mucosal vaccine against Shigella and ETEC infection.
Altboum Z; Barry EM; Losonsky G; Galen JE; Levine MM
Infect Immun; 2001 May; 69(5):3150-8. PubMed ID: 11292735
[TBL] [Abstract][Full Text] [Related]
6. Further characterization of delta aroA delta virG Shigella flexneri 2a strain CVD 1203 as a mucosal Shigella vaccine and as a live-vector vaccine for delivering antigens of enterotoxigenic Escherichia coli.
Noriega FR; Losonsky G; Wang JY; Formal SB; Levine MM
Infect Immun; 1996 Jan; 64(1):23-7. PubMed ID: 8557344
[TBL] [Abstract][Full Text] [Related]
7. Engineered deltaguaB-A deltavirG Shigella flexneri 2a strain CVD 1205: construction, safety, immunogenicity, and potential efficacy as a mucosal vaccine.
Noriega FR; Losonsky G; Lauderbaugh C; Liao FM; Wang JY; Levine MM
Infect Immun; 1996 Aug; 64(8):3055-61. PubMed ID: 8757833
[TBL] [Abstract][Full Text] [Related]
8. Characterization of a multicomponent live, attenuated Shigella flexneri vaccine.
DeLaine BC; Wu T; Grassel CL; Shimanovich A; Pasetti MF; Levine MM; Barry EM
Pathog Dis; 2016 Jul; 74(5):. PubMed ID: 27106253
[TBL] [Abstract][Full Text] [Related]
9. Construction and characterization of attenuated delta aroA delta virG Shigella flexneri 2a strain CVD 1203, a prototype live oral vaccine.
Noriega FR; Wang JY; Losonsky G; Maneval DR; Hone DM; Levine MM
Infect Immun; 1994 Nov; 62(11):5168-72. PubMed ID: 7927802
[TBL] [Abstract][Full Text] [Related]
10. Live Shigella flexneri 2a and Shigella sonnei I vaccine candidate strains with two attenuating markers. I. Construction of vaccine candidate strains with retained invasiveness but reduced intracellular multiplication.
Linde K; Dentchev V; Bondarenko V; Marinova S; Randhagen B; Bratoyeva M; Tsvetanov Y; Romanova Y
Vaccine; 1990 Feb; 8(1):25-9. PubMed ID: 2180230
[TBL] [Abstract][Full Text] [Related]
11. AroD deletion attenuates Shigella flexneri strain 2457T and makes it a safe and efficacious oral vaccine in monkeys.
Kärnell A; Cam PD; Verma N; Lindberg AA
Vaccine; 1993; 11(8):830-6. PubMed ID: 8356844
[TBL] [Abstract][Full Text] [Related]
12. An auxotrophic live oral Shigella flexneri vaccine: development and testing.
Kärnell A; Stocker BA; Katakura S; Sweiha H; Reinholt FP; Cam PD; Trach DD; Lindberg AA
Rev Infect Dis; 1991; 13 Suppl 4():S357-61. PubMed ID: 2047663
[TBL] [Abstract][Full Text] [Related]
13. Auxotrophic live oral Shigella flexneri vaccine protects monkeys against challenge with S. flexneri of different serotypes.
Kärnell A; Sweiha H; Lindberg AA
Vaccine; 1992; 10(3):167-74. PubMed ID: 1557932
[TBL] [Abstract][Full Text] [Related]
14. Immunogenicity of multivalent Shigella-ETEC candidate vaccine strains in a guinea pig model.
Barry EM; Wang J; Wu T; Davis T; Levine MM
Vaccine; 2006 May; 24(18):3727-34. PubMed ID: 16169130
[TBL] [Abstract][Full Text] [Related]
15. Stable Chromosomal Expression of Shigella flexneri 2a and 3a O-Antigens in the Live Salmonella Oral Vaccine Vector Ty21a.
Dharmasena MN; Osorio M; Takeda K; Stibitz S; Kopecko DJ
Clin Vaccine Immunol; 2017 Dec; 24(12):. PubMed ID: 29046309
[TBL] [Abstract][Full Text] [Related]
16. Strategy for cross-protection among Shigella flexneri serotypes.
Noriega FR; Liao FM; Maneval DR; Ren S; Formal SB; Levine MM
Infect Immun; 1999 Feb; 67(2):782-8. PubMed ID: 9916090
[TBL] [Abstract][Full Text] [Related]
17. Construction and evaluation of a virG thyA double mutant of Shigella flexneri 2a as a candidate live-attenuated oral vaccine.
Yoshikawa M; Sasakawa C; Okada N; Takasaka M; Nakayama M; Yoshikawa Y; Kohno A; Danbara H; Nariuchi H; Shimada H
Vaccine; 1995; 13(15):1436-40. PubMed ID: 8578822
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the safety, immunogenicity, and efficacy in healthy adults of four doses of live oral hybrid Escherichia coli-Shigella flexneri 2a vaccine strain EcSf2a-2.
Kotloff KL; Losonsky GA; Nataro JP; Wasserman SS; Hale TL; Taylor DN; Newland JW; Sadoff JC; Formal SB; Levine MM
Vaccine; 1995 Apr; 13(5):495-502. PubMed ID: 7639017
[TBL] [Abstract][Full Text] [Related]
19. Virulence phenotype and genetic characteristics of the T32-ISTRATI Shigella flexneri 2a vaccine strain.
Venkatesan M; Fernandez-Prada C; Buysse JM; Formal SB; Hale TL
Vaccine; 1991 May; 9(5):358-63. PubMed ID: 1872021
[TBL] [Abstract][Full Text] [Related]
20. Immunogenicity and characterization of WRSF2G11: a second generation live attenuated Shigella flexneri 2a vaccine strain.
Ranallo RT; Thakkar S; Chen Q; Venkatesan MM
Vaccine; 2007 Mar; 25(12):2269-78. PubMed ID: 17229494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]